PT - JOURNAL ARTICLE AU - J H Bae AU - T-G Kwon AU - D-W Hyun AU - C S Rihal AU - A Lerman TI - Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study AID - 10.1136/hrt.2007.135822 DP - 2008 Dec 01 TA - Heart PG - 1559--1564 VI - 94 IP - 12 4099 - http://heart.bmj.com/content/94/12/1559.short 4100 - http://heart.bmj.com/content/94/12/1559.full SO - Heart2008 Dec 01; 94 AB - Objectives: Slow flow phenomenon is a serious complication of percutaneous coronary intervention (PCI) and is associated with a poor prognosis. We sought to evaluate the characteristics of lesions predisposing to the slow/no-reflow phenomenon during primary PCI in patients with acute myocardial infarction.Methods: The study subjects consisted of 57 consecutive patients (mean age 58.5 (SD 14.5) years, 45 males) who underwent primary PCI for acute myocardial infarction and intravascular ultrasound-virtual histology (IVUS-VH) examination. Slow flow was defined as ⩽ thrombolysis in myocardial infarction grade 2 after PCI.Results: Slow flow developed in 12 patients (eight males). Patients with slow flow were likely to be older (67.5 (13.8) years vs 56.2 (13.9) years, p = 0.015), had more cardiogenic shock (16.7% vs 2.2%, p = 0.046), larger fibrofatty volume over the entire lesion length (36.7 (25.5) mm3 vs 18.0 (18.6) mm3, p = 0.006), higher remodelling index (1.10 (0.17) vs 0.99 (0.16), p = 0.043), larger plaque area (16.2 (5.4) mm2 vs 12.5 (4.9) mm2, p = 0.025), fibrous area (8.0 (3.3) mm2 vs 5.4 (3.0) mm2, p = 0.014) and fibrofatty area (2.7 (2.2) mm2 vs 1.3 (1.6) mm2, p = 0.016) at the minimal lumen site than those without slow flow (37 males). Multivariate analysis revealed that the fibrofatty volume over the entire lesion length was the only independent factor (β = 0.359, 95% confidence interval 0.002 to 0.012, p = 0.006) for slow flow during primary PCI.Conclusions: This study suggests that slow flow may be dependent on the tissue characterisation (fibrofatty volume) of the underlying lesion at the time of the primary PCI for acute myocardial infarction.